India, Aug. 27 -- image credit- shutterstock

Aqualab, theDirect-to-Retaildivision of Haryana-based Laborate Pharmaceuticals India Ltd, has crossed theRs 100 crore revenuemark within three years of launch and now expects to touch Rs250 crore by FY 25-26.The growth has been driven by an expanding portfolio of over800 SKUsand a network of500+ retail stockists, with Tier-II and Tier-III markets contributing a rising share of sales.

Since its inception in 2022, the division has reported consistent year-on-year growth, moving from Rs 76 crore in FY 2022-23 to Rs 108 crore in FY 2023-24, Aqualab has focused on ensuring affordability and last-mile access, enabling its medicines to reach smaller towns alongside metropolitan centres.

"We are now...